Terms: = Breast cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671
4076 results:
1. cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study.
Cunningham R; Stanley J; Imlach F; Haitana T; Lockett H; Every-Palmer S; Clark MTR; Lacey C; Telfer K; Peterson D
BMC Cancer; 2024 Apr; 24(1):546. PubMed ID: 38689242
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction.
Yuan J; Zhang M; Wang M; Zhang M; Wu K; Chen H
Sci Rep; 2024 Apr; 14(1):9208. PubMed ID: 38649431
[TBL] [Abstract] [Full Text] [Related]
3. Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.
Meng X; Hao F; Wang N; Qin P; Ju Z; Sun D
BMC Med Res Methodol; 2024 Apr; 24(1):90. PubMed ID: 38637725
[TBL] [Abstract] [Full Text] [Related]
4. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With breast cancer.
Bhimani J; O'Connell K; Ergas IJ; Foley M; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Bowles EJA; Bandera EV; Kushi LH; Kantor ED
JCO Clin Cancer Inform; 2024 Apr; 8():e2300209. PubMed ID: 38635936
[TBL] [Abstract] [Full Text] [Related]
5. Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
Gill J; Yendamuri K; Chatterjee U; Yao S; Oladeru OT; Singh AK; Ma SJ
BMC Cancer; 2024 Apr; 24(1):461. PubMed ID: 38614979
[TBL] [Abstract] [Full Text] [Related]
6. Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021.
Johansson ALV; Kønig SM; Larønningen S; Engholm G; Kroman N; Seppä K; Malila N; Steig BÁ; Gudmundsdóttir EM; Ólafsdóttir EJ; Lundberg FE; Andersson TM; Lambert PC; Lambe M; Pettersson D; Aagnes B; Friis S; Storm H
Acta Oncol; 2024 Apr; 63():179-191. PubMed ID: 38597666
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathological characteristics and immune microenvironment of breast squamous cell carcinoma].
Liang JY; Wang YM; Wen Z; Zhang WH; Gao ZZ; Wang Z; Guo SP
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):337-343. PubMed ID: 38556816
[No Abstract] [Full Text] [Related]
8. Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in breast cancer.
Khoury T; Mendicino L; Payne Ondracek R; Yao S; Davis W; Omilian AR; Kwan ML; Roh JM; D'Addario L; Valice E; Fernandez D; Ergas IJ; Chua AV; Ambrosone CB; Kushi LH
JAMA Netw Open; 2024 Mar; 7(3):e243345. PubMed ID: 38517439
[TBL] [Abstract] [Full Text] [Related]
9. Medical Home Implementation and Follow-Up of cancer-Related Abnormal Test Results in the Veterans Health Administration.
Rajan SS; Sarvepalli S; Wei L; Meyer AND; Murphy DR; Choi DT; Singh H
JAMA Netw Open; 2024 Mar; 7(3):e240087. PubMed ID: 38483392
[TBL] [Abstract] [Full Text] [Related]
10. Disease-free survival as a surrogate for overall survival in HR+/HER2- early breast cancer: A correlation analysis.
Untch M; Pérol D; Mayer EL; Cortes J; Nusch A; Cameron D; Barrios C; Delea T; Danyliv A; Mishra N; Gupta R; Pathak P; Fasching PA
Eur J Cancer; 2024 May; 202():113977. PubMed ID: 38460476
[TBL] [Abstract] [Full Text] [Related]
11. A mixed-method study evaluating an innovative care model for rural patients undergoing outpatient breast surgery.
Chiu S; Fowler S; Bridges S; Hanson N; King J; Street S; Tait H; Irving K; McLean P; McLaughlin L; Gulliver A
Can J Surg; 2024; 67(2):E77-E84. PubMed ID: 38453350
[TBL] [Abstract] [Full Text] [Related]
12. Validation of artificial intelligence contrast mammography in diagnosis of breast cancer: Relationship to histopathological results.
Helal M; Khaled R; Alfarghaly O; Mokhtar O; Elkorany A; Fahmy A; El Kassas H
Eur J Radiol; 2024 Apr; 173():111392. PubMed ID: 38428255
[TBL] [Abstract] [Full Text] [Related]
13. Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
Ben-Zion Berliner M; Yust-Katz S; Lavie I; Goldberg Y; Kedar I; Yerushalmi R
BMC Cancer; 2024 Feb; 24(1):219. PubMed ID: 38365640
[TBL] [Abstract] [Full Text] [Related]
14. Resistance Training-Induced Gains in Muscle Strength and Power Mediate the Improvement in Walking Speed in Middle-Aged Women Who Are breast cancer Survivors.
Santagnello SB; Martins FM; de Oliveira Junior GN; de Sousa JFR; Nomelini RS; Murta EFC; Orsatti FL
J Strength Cond Res; 2024 Apr; 38(4):773-782. PubMed ID: 38354372
[TBL] [Abstract] [Full Text] [Related]
15. breast cancer in a Hispanic patient with Werner syndrome.
Santos MM; Baerga CG; Lamsal S; Engel C; Ozdemir S
J Radiol Case Rep; 2023 Oct; 17(10):21-31. PubMed ID: 38343885
[TBL] [Abstract] [Full Text] [Related]
16. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
Abrahão R; Brunson A; Ruddy KJ; Li Q; Li J; Ryder MM; Chubak J; Nichols HB; Sauder CAM; Gray MF; Hahn EE; Wun T; Keegan THM
Br J Cancer; 2024 Apr; 130(7):1166-1175. PubMed ID: 38332179
[TBL] [Abstract] [Full Text] [Related]
17. Psychosocial interventions for improving mental health and family functioning in families with parental cancer: A systematic review.
Chong YY; Temesgen WA; Chan H; Wong CL; Cheng HY
Eur J Oncol Nurs; 2024 Feb; 68():102505. PubMed ID: 38309255
[TBL] [Abstract] [Full Text] [Related]
18. Isolating the effect of confounding from the observed survival benefit of screening participants - a methodological approach illustrated by data from the German mammography screening programme.
Buschmann L; Wellmann I; Bonberg N; Wellmann J; Hense HW; Karch A; Minnerup H
BMC Med; 2024 Jan; 22(1):43. PubMed ID: 38287392
[TBL] [Abstract] [Full Text] [Related]
19. Effect of comorbidity and multimorbidity on adherence to follow-up recommendations among long-term breast cancer survivors.
Abbad-Gomez D; Domingo L; Comas M; Santiá P; Jansana A; Poblador B; Sanz T; Del Cura I; Ibañez B; Padilla M; Redondo M; Castells X; Sala M
Maturitas; 2024 Apr; 182():107918. PubMed ID: 38280353
[TBL] [Abstract] [Full Text] [Related]
20. Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer.
Li X; Zhong X; Xu H; Wang J; Liu X; Wang Y; He L; Ma J; Li G; Liu L
Front Endocrinol (Lausanne); 2023; 14():1305429. PubMed ID: 38260126
[TBL] [Abstract] [Full Text] [Related]
[Next]
